Hopital Roger Salengro - CHU Lille

Lille 59037

1 studies enrolling now · 8 studies all time

What they study most

ALS, ARDS, Alzheimer Disease, Amyotrophic Lateral Sclerosis, Cerebral Stroke, Cognitive Dysfunction, Dementia, Ischemic Stroke; Ischemic Attack, Transient, Multiple Sclerosis, Relapsing-Remitting, Narcolepsy With Cataplexy

Studies at this site

• Careful Ventilation in Acute Respiratory Distress Syndrome (COVID-19 and Non-COVID-19) — Recruiting now
• A Study of Milvexian in Participants After an Acute Ischemic Stroke or High-Risk Transient Ischemic Attack- LIBREXIA-STROKE — Running, not enrolling
• A Study of JNJ-64042056 in Participants With Preclinical Alzheimer's Disease — Running, not enrolling
• A Study of JNJ-63733657 in Participants With Early Alzheimer's Disease — Stopped early
• CERENOVUS Neurothrombectomy Devices Registry — Completed
• A Study to Evaluate Efficacy, Safety, and Tolerability of EID of Natalizumab (BG00002) in Participants With RRMS Switching From Treatment With Natalizumab SID in Relation to Continued SID Treatment- Followed by Extension Study Comprising SC and IV Natalizumab Administration — Completed
• An Efficacy and Safety Study of Ravulizumab in ALS Participants — Stopped early
• A Study of the Efficacy and Safety of JZP-258 in Subjects With Narcolepsy With Cataplexy — Completed